Erlotinib is used for the treatment of metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) gene mutations.
Erlotinib
$1,603.29 – $6,413.15
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.